Irritable bowel syndrome Trials in Jackson, United States
Conditions / Irritable bowel syndrome / Jackson, United States
Irritable bowel syndrome has been the subject of sustained clinical investigation across multiple research sites.
14 total trials for this combination
Showing top 10 of 14 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT00547469 | A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females | UNKNOWN | PHASE2/PHASE3 |
| NCT01553747 | Efficacy, Safety, and Tolerability of Eluxadoline in the Treatment of Participants With Diarrhea-Predominant Irritable Bowel Syndrome (IBS-d) | COMPLETED | PHASE3 |
| NCT01553591 | Efficacy, Safety, and Tolerability of Eluxadoline in the Treatment of Participants With Diarrhea-Predominant Irritable Bowel Syndrome (IBS-d) | COMPLETED | PHASE3 |
| NCT00454688 | Asimadoline for the Treatment of Subjects With Irritable Bowel Syndrome | COMPLETED | PHASE2 |
| NCT00269412 | Study to Assess the Efficacy and Safety of Rifaximin Administered BID in the Treatment of Patients With Diarrhea-Associated Irritable Bowel Syndrome | COMPLETED | PHASE2 |
| NCT01130272 | Efficacy, Safety, and Tolerability of JNJ-27018966 (Eluxadoline) in the Treatment of Irritable Bowel Syndrome With Diarrhea | COMPLETED | PHASE2 |
| NCT02706483 | Long Term Safety Study of Plecanatide | COMPLETED | PHASE3 |
| NCT03806127 | Study to Evaluate the Efficacy and Safety of Vibegron Administered Orally for 12 Weeks to Women With Irritable Bowel Syndrome | COMPLETED | PHASE2 |
| NCT00486876 | A Study of 3 Doses of Dextofisopam in Females With Irritable Bowel Syndrome | COMPLETED | PHASE2 |
| NCT01494233 | A Multi-Center Trial to Determine the Safety and Efficacy of LX1033 in Subjects With Diarrhea-Predominant Irritable Bowel Syndrome | COMPLETED | PHASE2 |